According to CNN, Rep. Tom Price last year bought shares in a defective medical device manufacturer days before introducing legislation that would have directly benefited the company, raising new ethics concerns for President-elect Donald Trump’s nominee for Health and Human Services secretary.
- MDL 2158 Zimmer Durom Hip Cup Products Liability Litigation, where 463 cases are consolidated before U.S. District Judge Susan D. Wigenton in New Jersey. The plaintiffs charge the replacement hip was defectively designed or manufactured, and that Zimmer failed to provide adequate warnings about it.
- MDL 2272 Zimmer NexGen Knee Product Liability Litigation, where 501 cases are consolidated before U.S. District Judge Rebecca R. Pallmeyer in the Northern District of Illinois. Four cases have been scheduled for bellwether trials, where plaintiffs suffered loosening of the replacement knee or had to have it removed and replaced.
After Price offered his bill to provide Zimmer Biomet and other companies relief from the CMS regulation, the company’s political action committee donated to the congressman’s reelection campaign, records show.